We have recruited over 1000 patients for a study in which we follow their disease status over time, together with blood and tissue samples. These cases and specimens have provided great insight into MCC causes and potential therapies and will continue to be an important resource for MCC researchers well into the future.
Currently, we are focusing our recruiting efforts on several existing and planned trials to augment the immune response in MCC.
For further details on participating in research studies, please see our Announcements.
For further information on current Merkel cell clinical trials, click here.
The authoritative source on Merkel cell carcinoma.
June 26, 2017